PEA15
From Wikipedia, the free encyclopedia
|
Phosphoprotein enriched in astrocytes 15
|
||||||||||||||
| PDB rendering based on 1n3k. | ||||||||||||||
| Available structures: 1n3k | ||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | PEA15; MAT1; PED; HMAT1; HUMMAT1H; MAT1H; PEA-15 | |||||||||||||
| External IDs | OMIM: 603434 MGI: 104799 HomoloGene: 7884 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 8682 | 18611 | ||||||||||||
| Ensembl | ENSG00000162734 | ENSMUSG00000013698 | ||||||||||||
| Uniprot | Q15121 | Q62048 | ||||||||||||
| Refseq | NM_003768 (mRNA) NP_003759 (protein) |
NM_011063 (mRNA) NP_035193 (protein) |
||||||||||||
| Location | Chr 1: 158.44 - 158.45 Mb | Chr 1: 174.03 - 174.04 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Phosphoprotein enriched in astrocytes 15, also known as PEA15, is a human gene.[1]
PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes.[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Araujo H, Danziger N, Cordier J, et al. (1993). "Characterization of PEA-15, a major substrate for protein kinase C in astrocytes.". J. Biol. Chem. 268 (8): 5911-20. PMID 8449955.
- Estellés A, Yokoyama M, Nothias F, et al. (1996). "The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human.". J. Biol. Chem. 271 (25): 14800-6. PMID 8662970.
- Hwang S, Kuo WL, Cochran JF, et al. (1997). "Assignment of HMAT1, the human homolog of the murine mammary transforming gene (MAT1) associated with tumorigenesis, to 1q21.1, a region frequently gained in human breast cancers.". Genomics 42 (3): 540-2. PMID 9205133.
- Condorelli G, Vigliotta G, Iavarone C, et al. (1998). "PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus.". EMBO J. 17 (14): 3858-66. doi:. PMID 9670003.
- Kubes M, Cordier J, Glowinski J, et al. (1998). "Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro.". J. Neurochem. 71 (3): 1307-14. PMID 9721757.
- Condorelli G, Vigliotta G, Cafieri A, et al. (1999). "PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis.". Oncogene 18 (31): 4409-15. doi:. PMID 10442631.
- Kitsberg D, Formstecher E, Fauquet M, et al. (1999). "Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis.". J. Neurosci. 19 (19): 8244-51. PMID 10493725.
- Wolford JK, Bogardus C, Ossowski V, Prochazka M (2000). "Molecular characterization of the human PEA15 gene on 1q21-q22 and association with type 2 diabetes mellitus in Pima Indians.". Gene 241 (1): 143-8. PMID 10607908.
- Zhang Y, Redina O, Altshuller YM, et al. (2001). "Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them.". J. Biol. Chem. 275 (45): 35224-32. doi:. PMID 10926929.
- Formstecher E, Ramos JW, Fauquet M, et al. (2001). "PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase.". Dev. Cell 1 (2): 239-50. PMID 11702783.
- Condorelli G, Trencia A, Vigliotta G, et al. (2002). "Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function.". J. Biol. Chem. 277 (13): 11013-8. doi:. PMID 11790785.
- Xiao C, Yang BF, Asadi N, et al. (2002). "Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells.". J. Biol. Chem. 277 (28): 25020-5. doi:. PMID 11976344.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:. PMID 12477932.
- Vaidyanathan H, Ramos JW (2003). "RSK2 activity is regulated by its interaction with PEA-15.". J. Biol. Chem. 278 (34): 32367-72. doi:. PMID 12796492.
- Trencia A, Perfetti A, Cassese A, et al. (2003). "Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action.". Mol. Cell. Biol. 23 (13): 4511-21. PMID 12808093.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi:. PMID 14702039.
- Trencia A, Fiory F, Maitan MA, et al. (2004). "Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15.". J. Biol. Chem. 279 (45): 46566-72. doi:. PMID 15328349.
- Gaumont-Leclerc MF, Mukhopadhyay UK, Goumard S, Ferbeyre G (2004). "PEA-15 is inhibited by adenovirus E1A and plays a role in ERK nuclear export and Ras-induced senescence.". J. Biol. Chem. 279 (45): 46802-9. doi:. PMID 15331596.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi:. PMID 15489334.
- Renganathan H, Vaidyanathan H, Knapinska A, Ramos JW (2006). "Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD.". Biochem. J. 390 (Pt 3): 729-35. doi:. PMID 15916534.

